Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
Thomayant Prueksaritanont(United States Military Academy), Thomas A. Baillie(University of Washington), Bennett Ma(Merck Biopharma Co., Ltd. (Japan)), Jiunn H. Lin(Merck Biopharma Co., Ltd. (Japan)), Xiaojun Fang(Merck Biopharma Co., Ltd. (Japan)), Yue Qiu(Merck Biopharma Co., Ltd. (Japan)), Paul G. Pearson(Merck Biopharma Co., Ltd. (Japan)), Raju Subramanian(Gilead Sciences (United States))
Cited by 346
Related Papers
Effects of Fibrates on Metabolism of Statins in Human Hepatocytes
|Drug Metabolism and Disposition|2002|325
Comparison of Information-Dependent Acquisition, SWATH, and MS<sup>All</sup> Techniques in Metabolite Identification Study Employing Ultrahigh-Performance Liquid Chromatography–Quadrupole Time-of-Flight Mass Spectrometry
|Analytical Chemistry|2013|211
Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer
|Journal of Medicinal Chemistry|2008|157
Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry
|Journal of Mass Spectrometry|2006|153
Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors
|Journal of Medicinal Chemistry|2011|120